Next report date
Report period
Q2 2024
EPS estimate
5.99MXN
Revenue estimate
30.54 BMXN
21.72MXN
39.18 BMXN
133.78 BMXN
610.28 M
About CHUGAI PHARMACEUTICAL CO
Sector
CEO
Osamu Okuda
Headquarters
Tokyo
Website
Employees (FY)
7.6 K
Founded
1925
FIGI
BBG012VHDLR2
Chugai Pharmaceutical Co., Ltd. engages in the research, development, manufacturing, sale, importation, and exportation of pharmaceuticals. Its operations are carried out through the Domestic and Overseas businesses. The Domestic Business covers the manufacturing, research, and development operations in Japan. The Overseas business comprises of sales and production in Europe, Taiwan and China. The company was founded by Juzo Ueno on March 10, 1925 and is headquartered in Tokyo, Japan.
4519:TSE - CHUGAI PHARMACEUTICAL - Up 145% over 12 months.Japanese listed Chugai Pharmaceutical is in a nice steady up trend. Could be worth a watch.
Chugai Pharmaceutical Co., Ltd. engages in the research, development, manufacturing, sale, importation, and exportation of the pharmaceuticals. Its operations are carried out through the following business
4519, Chugai Pharmaceutical Co. - Trailing StopTSE:4519
The upward trend of one of our trades in the Japanese market continues.
We follow as always the not realized profit by ensuring more and more a Risk Reward as optimal as possible.
Good trading at all!
4519, Chugai Pharmaceutical Co. - Breakout on ascending triangleTSE:4519
Net breakout of the resistance of this ascending triangle.
As always, one of the parameters for deciding whether or not to enter our trade is the Yield Risk ratio, in which winning trades allow us both to compensate for the small losses we make 60% of the time and to create that extra marg
See all ideas
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
Frequently Asked Questions
The current price of 4519/N is 567.91 MXN — it hasn't changed in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on BMV exchange CHUGAI PHARMACEUTICAL CO stocks are traded under the ticker 4519/N.
CHUGAI PHARMACEUTICAL CO is going to release the next earnings report on Jul 25, 2024. Keep track of upcoming events with our Earnings Calendar.
4519/N stock is 0% volatile and has beta coefficient of 0.95. Check out the list of the most volatile stocks — is CHUGAI PHARMACEUTICAL CO there?
4519/N earnings for the last quarter are 6.67 MXN per share, whereas the estimation was 6.11 MXN resulting in a 9.18% surprise. The estimated earnings for the next quarter are 5.17 MXN per share. See more details about CHUGAI PHARMACEUTICAL CO earnings.
CHUGAI PHARMACEUTICAL CO revenue for the last quarter amounts to 32.96 B MXN despite the estimated figure of 34.35 B MXN. In the next quarter revenue is expected to reach 26.58 B MXN.
Yes, you can track CHUGAI PHARMACEUTICAL CO financials in yearly and quarterly reports right on TradingView.
4519/N net income for the last quarter is 8.15 B MXN, while the quarter before that showed 10.98 B MXN of net income which accounts for −25.80% change. Track more CHUGAI PHARMACEUTICAL CO financial stats to get the full picture.
Today CHUGAI PHARMACEUTICAL CO has the market capitalization of 882.45 B, it has increased by 1.84% over the last week.
CHUGAI PHARMACEUTICAL CO dividend yield was 1.50% in 2023, and payout ratio reached 40.44%. The year before the numbers were 2.32% and 34.26% correspondingly. See high-dividend stocks and find more opportunities for your portfolio.
Like other stocks, 4519/N shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade CHUGAI PHARMACEUTICAL CO stock right from TradingView charts — choose your broker and connect to your account.
As of Apr 27, 2024, the company has 7.60 K employees. See our rating of the largest employees — is CHUGAI PHARMACEUTICAL CO on this list?
We've gathered analysts' opinions on CHUGAI PHARMACEUTICAL CO future price: according to them, 4519/N price has a max estimate of 819.07 MXN and a min estimate of 497.41 MXN. Read a more detailed CHUGAI PHARMACEUTICAL CO forecast: see what analysts think of CHUGAI PHARMACEUTICAL CO and suggest that you do with its stocks.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. CHUGAI PHARMACEUTICAL CO EBITDA is 46.71 B MXN, and current EBITDA margin is 40.26%. See more stats in CHUGAI PHARMACEUTICAL CO financial statements.